Cargando…

Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017–2019

OBJECTIVES: To assess the global and regional distribution of ESBLs in Enterobacterales and carbapenemases in Enterobacterales and Pseudomonas aeruginosa. METHODS: Antimicrobial susceptibility of isolates collected from ATLAS (2017–2019) was determined per CLSI guidelines. Enterobacterales exhibitin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gales, Ana C, Stone, Gregory, Sahm, Daniel F, Wise, Mark G, Utt, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320057/ https://www.ncbi.nlm.nih.gov/pubmed/37161662 http://dx.doi.org/10.1093/jac/dkad127

Ejemplares similares

Detection of Multidrug-Resistant Enterobacterales—From ESBLs to Carbapenemases
por: Noster, Janina, et al.
Publicado: (2021)

Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
por: Wielders, Cornelia C. H., et al.
Publicado: (2022)

2149. In vitro Activity of Aztreonam-avibactam and Comparator Agents Against Carbapenem-Resistant Enterobacterales With and Without Carbapenemases, ATLAS Global Surveillance Program, 2017–2021
por: Wise, Mark G, et al.
Publicado: (2023)

1268. In Vitro Activity of Ceftazidime-Avibactam and Comparators against KPC-Producing Enterobacterales and Pseudomonas aeruginosa Collected in China as Part of the ATLAS Global Surveillance Program in 2019
por: Wise, Mark G G, et al.
Publicado: (2021)

Mobile Carbapenemase Genes in Pseudomonas aeruginosa
por: Yoon, Eun-Jeong, et al.
Publicado: (2021)

1580. In Vitro Activity of Ceftazidime-Avibactam Against Enterobacterales and Pseudomonas aeruginosa Collected in Latin America as part of the ATLAS Global Surveillance Program, 2017-2019
por: Kazmierczak, Krystyna, et al.
Publicado: (2020)

In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019
por: Karlowsky, James A., et al.
Publicado: (2021)

Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge
por: Tenover, Fred C., et al.
Publicado: (2022)

The Changing Epidemiology of Carbapenemase-Producing Enterobacterales
por: Hussein, Khetam, et al.
Publicado: (2022)

Prevalence of ESBL, AmpC and Carbapenemase-Producing Enterobacterales Isolated from Raw Vegetables Retailed in Romania
por: Colosi, Ioana Alina, et al.
Publicado: (2020)

Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa
por: Gill, Christian M., et al.
Publicado: (2023)

Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
por: Ramette, Alban, et al.
Publicado: (2021)

Treatment of infections caused by carbapenemase-producing Enterobacterales
por: Íñigo, Melania, et al.
Publicado: (2022)

1571. In Vitro Activity of Ceftazidime-Avibactam and Comparator Agents Against MDR Enterobacterales and Pseudomonas aeruginosa Collected in Latin America During the ATLAS Global Surveillance Program 2017-2018
por: Kazmierczak, Krystyna, et al.
Publicado: (2020)

1719. In Vitro Activity of Ceftazidime-avibactam and Comparator Agents against Enterobacterales and Pseudomonas aeruginosa Collected from Patients with Bloodstream Infections as Part of the ATLAS Global Surveillance Program, 2017-2020
por: Estabrook, Mark, et al.
Publicado: (2022)

High incidence of carbapenemase-producing Pseudomonas aeruginosa clinical isolates from Lagos, Nigeria
por: Olalekan, Adesola, et al.
Publicado: (2023)

Development and Application of a Pragmatic Algorithm to Guide Definitive Carbapenemase Testing to Identify Carbapenemase-Producing Pseudomonas aeruginosa
por: Gill, Christian M., et al.
Publicado: (2020)

The Rapid Carbapenemase Detection Method (rCDM) for Rapid and Accurate Detection of Carbapenemase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
por: Jing, Xiaopeng, et al.
Publicado: (2019)

Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019
por: Estabrook, Mark, et al.
Publicado: (2023)

Detection of Extended-Spectrum β-Lactamases (ESBLs) and AmpC in Class A and Class B Carbapenemase-Producing Enterobacterales
por: Imkamp, Frank, et al.
Publicado: (2022)

Hospital effluent: A reservoir for carbapenemase-producing Enterobacterales?
por: Cahill, Niamh, et al.
Publicado: (2019)

Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan
por: Habib, Amina, et al.
Publicado: (2022)

Detection and Characterization of Carbapenemases in Enterobacterales With a New Rapid and Simplified Carbapenemase Detection Method Called rsCDM
por: Liao, Quanfeng, et al.
Publicado: (2022)

Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study
por: Willems, Roel P J, et al.
Publicado: (2021)

Retrospective Data Insight into the Global Distribution of Carbapenemase-Producing Pseudomonas aeruginosa
por: Wang, Min-Ge, et al.
Publicado: (2021)

Dialysis Water Supply Faucet as Reservoir for Carbapenemase-Producing Pseudomonas aeruginosa
por: Prestel, Christopher, et al.
Publicado: (2022)

Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa
por: Correa-León, Yoselin Paola, et al.
Publicado: (2023)

Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012–2018
por: Räisänen, Kati, et al.
Publicado: (2020)

Susceptibility of Clinical Enterobacterales Isolates With Common and Rare Carbapenemases to Mecillinam
por: Fuchs, Frieder, et al.
Publicado: (2021)

Association of Carbapenemase-Producing Enterobacterales Detected in Stream and Clinical Samples
por: Sung, Gyung-Hye, et al.
Publicado: (2022)

Paradoxical consequences of wastewater interventions targeting carbapenemase-producing Enterobacterales
por: Lehman, David, et al.
Publicado: (2023)

2760. Fecal Microbiota Transplantation for Decolonization of Carbapenemase-Producing Enterobacterales
por: Davido, Benjamin, et al.
Publicado: (2023)

Replacement of the Double Meropenem Disc Test with a Lateral Flow Assay for the Detection of Carbapenemase-Producing Enterobacterales and Pseudomonas aeruginosa in Clinical Laboratory Practice
por: Tychala, Areti, et al.
Publicado: (2023)

Detection of carbapenemase production in Enterobacteriaceae and Pseudomonas species by carbapenemase Nordmann–Poirel test
por: Rao, Morubagal R., et al.
Publicado: (2019)

Dissemination of carbapenemase-producing Enterobacterales in Ireland from 2012 to 2017: a retrospective genomic surveillance study
por: Hadjirin, Nazreen F., et al.
Publicado: (2023)

Evaluation of a Shotgun Metagenomics Approach for Detection of ESBL- and/or Carbapenemase-Producing Enterobacterales in Culture Negative Patients Recovered from Acute Leukemia
por: Lumbreras-Iglesias, Pilar, et al.
Publicado: (2023)

728. Potential Reservoirs for Additional Carbapenemase Gene Spread: Detection of Carbapenemase Genes in non-Pseudomonas aeruginosa and non-Acinetobacter baumannii isolates
por: Sabour, Sarah, et al.
Publicado: (2023)

1264. In Vitro Activity of Ceftazidime-Avibactam and Comparator Agents Against Enterobacterales and Pseudomonas aeruginosa Collected < 48 Hours and ≥48 Hours Post-Admission from Pediatric Patients, ATLAS Surveillance Program 2016-2019
por: Kazmierczak, Krystyna, et al.
Publicado: (2021)

The Intriguing Carbapenemases of Pseudomonas aeruginosa: Current Status, Genetic Profile, and Global Epidemiology
por: Hammoudi Halat, Dalal, et al.
Publicado: (2022)

Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods
por: Cortazzo, Venere, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_scrt8cn1ne68lbj67kcm5ti4ip